![Anthony Giordano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Giordano
Directeur Technique/Scientifique/R&D chez
AI FINANCIAL CORPORATION
Profil
Anthony Giordano was the founder of Message Pharmaceuticals, Inc. (1997), holding the title of Vice President-Research in 2008.
Dr. Giordano is the founder of TheraVasc, Inc. (2009), holding the title of President, Chief Executive Officer & Director.
Dr. Giordano is the founder of Merand Pharmaceuticals, Inc. (2018), holding the title of President & Chief Executive Officer.
Dr. Giordano is also the founder of Cognition Therapeutics, Inc. Dr. Giordano is currently the President, Chief Executive Officer & Director of NeuroTherapia, Inc. Dr. Giordano is currently the Chief Scientific Officer of ALT5 Sigma Corp.
Former positions include President, Chief Executive Officer & Director at Sulfagenix, Inc. (2014-2017), Director-Experimental Therapeutics at Feist-Weiller Cancer Center, Senior Scientist at Abbott Laboratories, President at Nucleonics, Inc., Adjunct Professor at Case Western Reserve University, Assistant Dean at Louisiana State University, President at Alteris Therapeutics, Inc., and Chief Scientific Officer at Acceptys, Inc. Education includes a doctorate from The Ohio State University, conferred in 1988.
Postes actifs de Anthony Giordano
| Sociétés | Poste | Début |
|---|---|---|
| AI FINANCIAL CORPORATION | Directeur Technique/Scientifique/R&D | 03/12/2019 |
TheraVasc, Inc.
 TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops treatments for various chronic medical diseases | Fondateur | 01/08/2009 |
Merand Pharmaceuticals, Inc.
 Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Général | 01/01/2018 |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Directeur Général | 01/12/2019 |
Anciens postes connus de Anthony Giordano
| Sociétés | Poste | Fin |
|---|---|---|
Sulfagenix, Inc.
 Sulfagenix, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur Général | 01/08/2017 |
Message Pharmaceuticals, Inc.
 Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Fondateur | 01/01/2008 |
Feist-Weiller Cancer Center | Corporate Officer/Principal | - |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Anthony Giordano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
JanOne, Inc.
 JanOne, Inc. Environmental ServicesIndustrial Services Provides turnkey appliance recycling and replacement services | Industrial Services |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | Health Technology |
Sulfagenix, Inc.
Sulfagenix, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Louisiana State University
Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alteris Therapeutics, Inc.
 Alteris Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic cancer vaccine products | Health Technology |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Acceptys, Inc.
 Acceptys, Inc. Pharmaceuticals: MajorHealth Technology Develops natural antibody technologies for infectious disease applications | Health Technology |
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops treatments for various chronic medical diseases | Health Technology |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
Merand Pharmaceuticals, Inc.
Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Feist-Weiller Cancer Center |
